LEADER 05315nam 2200637 450 001 9910787804503321 005 20230807204504.0 010 $a1-61705-141-1 035 $a(CKB)2670000000573352 035 $a(EBL)1827582 035 $a(SSID)ssj0001367456 035 $a(PQKBManifestationID)12613004 035 $a(PQKBTitleCode)TC0001367456 035 $a(PQKBWorkID)11444356 035 $a(PQKB)11564616 035 $a(MiAaPQ)EBC1827582 035 $a(Au-PeEL)EBL1827582 035 $a(CaPaEBR)ebr10962306 035 $a(CaONFJC)MIL655049 035 $a(OCoLC)894629981 035 $a(EXLCZ)992670000000573352 100 $a20150105h20152015 uy 0 101 0 $aeng 135 $aur|n|---||||| 181 $ctxt 182 $cc 183 $acr 200 00$aASPC manual of preventive cardiology /$feditors, Nathan D. Wong, Ezra A. Amsterdam, and Roger S. Blumenthal 210 1$aNew York :$cdemosMEDICAL,$d2015. 210 4$dİ2015 215 $a1 online resource (295 p.) 300 $aDescription based upon print version of record. 311 $a1-936287-86-2 311 $a1-322-23769-7 320 $aIncludes bibliographical references at the end of each chapters and index. 327 $aCover; Title; Copyright; Contents; Contributors; Foreword; Preface; Acknowledgments; Share ASPC Manual of Preventive Cardiology; Chapter 1: National Burden of Cardiovascular Disease and Associated Risk Factors; Cardiovascular Disease; Mortality and Morbidity Attributable to CVD; Prevalence and Control of Cardiovascular Risk Factors; Subclinical Atherosclerosis; Ankle-Brachial Index; Economic Costs of Cardiovascular Disease; Summary; Acknowledgments; References; Chapter 2: Cardiovascular Risk Assessment; Rationale for Contemporary CV Risk Prediction 327 $aRelative Risk Versus Absolute Cardiovascular RiskTreatment Benefit Depends on Absolute Risk Rather Than Relative Risk; Multiple, Online Risk Prediction Tools for CVD are Widely Available; Current Guideline Recommendations; Current Clinical Practice Guidelines Suggest That the Indication and Intensity of Treatment Should Be Proportional to the Absolute Risk for CVD; Novel Developments in Global CVD Risk: Considering Alternative CVD Outcomes; Novel Developments in Global CVD Risk: Considering Alternative Risk Factors; Novel Serum Markers; Novel Imaging Markers; Other Risk Markers 327 $aNovel Developments in Global CVD Risk: Considering Long-Term or Lifetime RiskConclusion; References; Chapter 3: The New American Prevention Guidelines: Aligning the Guidelines for Atherosclerotic Cardiovascular Risk Reduction With the Evidence; A New Approach; Major Themes; What You Need to Know; A. Heart Healthy Nutrition and Physical Activity Behaviors; B. Recommendations from the Risk Assessment Workgroup With Those Reflecting Expert Opinion Highlighted in Italics; C. Graded Recommendations for Statin Treatment to Reduce ASCVD Risk 327 $aFootnotes to this Section (from the Cholesterol Guideline Report)Statin Safety Recommendations; Footnotes to this Section (from the Cholesterol Guideline Report); Monitoring Statin Therapy; Optimizing Statin Therapy; Insufficient Response to Statin Therapy; Footnotes to this Section (from the Cholesterol Guideline Report); Conclusions; References; Chapter 4: Management of High Blood Pressure; Epidemiology of Hypertension; Definition and Classification of Hypertension; Initial Evaluation of the Patient; Thresholds for Initiating Therapy; Lifestyle Modifications; Initial Drug Therapy 327 $aGoal Blood Pressure for "Uncomplicated" Hypertensive PatientsGoal Blood Pressure for Hypertensive Patients with Other High-Risk Conditions; Other Issues; References; Chapter 5: Smoking and Passive Smoking; Smoking and Cardiovascular Disease; Secondhand Smoke; Trends in Cigarette Smoking; Prevention and Reduction of Tobacco Use Among Youth; Prevention and Cessation Programs for Adults; Cessation Strategies for Individuals; Behavioral Treatments; Pharmacologic Interventions; Clinical Approaches; Conclusions; References; Chapter 6: Metabolic Syndrome; History, Prevalence, and Epidemiology 327 $aDefinition 330 $aEndorsed by the American Society for Preventive Cardiology, this highly practical resource focuses on the application of current guidelines and practice standards in the clinical management of cardiovascular risk factors. The Manual presents concise descriptions of each major cardiovascular risk factor, and practical, to-the-point discussions of current best practices in clinical management. In addition, the Manual includes chapters on peripheral arterial disease, stroke, smoking, contemporary cardiovascular imaging, heart failure, metabolic syndrome, thrombosis, nutrition, special populations 606 $aCardiovascular system$xDiseases$xPrevention 615 0$aCardiovascular system$xDiseases$xPrevention. 676 $a616.1/05 702 $aWong$b Nathan D. 702 $aAmsterdam$b Ezra A. 702 $aBlumenthal$b Roger S. 712 02$aAmerican Society for Preventive Cardiology, 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910787804503321 996 $aASPC manual of preventive cardiology$92486349 997 $aUNINA